In this study, we investigated the metabolic effects of SR4 and niclosamide (Figure 1A), two small molecules that were recently identified as mitochondria uncouplers, against treatment naïve wild type, BRAFV600E and NRAS mutant, and BRAF inhibitor (vemurafenib)-resistant melanomas. The gene discussed is BRAF; the disease is melanoma.